Noble Wealth Management PBC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.83K Hold
7
– – ﹤0.01% 587
2026
Q2
$1.76K Buy
+7
New +$1.51K ﹤0.01% 596
2026
Q1
– Sell
-43
Closed -$9.82K – 588
2025
Q4
$9.82K Hold
43
– – ﹤0.01% 462
2025
Q3
$9.96K Buy
+43
New +$8.76K 0.01% 441
2025
Q1
$9.01K Hold
43
– – 0.01% 395
2024
Q4
$7.64K Buy
+43
New +$7.91K 0.01% 366

Other funds holding ABBV

Noble Wealth Management PBC's ABBV Position: Q3 2026 in Review

Noble Wealth Management PBC held its AbbVie (ABBV) position steady in Q3 2026 at 7 shares worth $1.83K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Noble Wealth Management PBC first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.96K in Q3 2025. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Noble Wealth Management PBC held 7 shares of AbbVie worth $1.83K as of Q3 2026.
  • Noble Wealth Management PBC left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #587 holding.
  • Noble Wealth Management PBC first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Noble Wealth Management PBC's AbbVie position peaked at $9.96K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.